These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17699164)

  • 1. More about the "ARB MI paradox".
    Hall AS; Strauss MH
    Heart; 2007 Sep; 93(9):1011-4. PubMed ID: 17699164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
    Reboldi G; Angeli F; Cavallini C; Gentile G; Mancia G; Verdecchia P
    J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses.
    Onuigbo MA
    Arch Intern Med; 2009 Oct; 169(19):1810; author reply 1810-1. PubMed ID: 19858442
    [No Abstract]   [Full Text] [Related]  

  • 4. Renin-angiotensin system and cardiovascular risk.
    Strauss MH; Hall A
    Lancet; 2007 Jul; 370(9581):23-4; author reply 24-5. PubMed ID: 17617258
    [No Abstract]   [Full Text] [Related]  

  • 5. Do angiotensin receptor blockers prevent myocardial infarctions as well as other initial therapies?
    Singh A; Bangalore S
    Curr Opin Cardiol; 2012 Jul; 27(4):381-5. PubMed ID: 22525329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the jury out? Class specific differences on coronary outcomes with ACE-inhibitors and ARBs: insight from meta-analysis and The Blood Pressure Lowering Treatment Trialists' Collaboration.
    Strauss MH; Lonn EM; Verma S
    Eur Heart J; 2005 Nov; 26(22):2351-3. PubMed ID: 16219656
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypertension therapy for type 2 diabetics].
    Bönner G
    MMW Fortschr Med; 2007 Jun; 149(23):45, 47-8. PubMed ID: 18062579
    [No Abstract]   [Full Text] [Related]  

  • 8. ARBs and ACEis together in the treatment of hypertension and its complications? current practical recommendations.
    Ruilope LM; Segura J
    Expert Opin Pharmacother; 2010 Nov; 11(16):2619-23. PubMed ID: 20977398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE inhibitors and ARBs: antihypertensive medications in CKD.
    Szromba C
    Nephrol Nurs J; 2005; 32(3):332-3. PubMed ID: 16035474
    [No Abstract]   [Full Text] [Related]  

  • 10. [Debate concerning the optimal blockage of the renin-angiotensin system].
    Choukroun G
    Nephrol Ther; 2010 Jan; 6 Spec No 1():H1-9. PubMed ID: 20129454
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    McMurray J; Solomon S; Pieper K; Reed S; Rouleau J; Velazquez E; White H; Howlett J; Swedberg K; Maggioni A; Køber L; Van de Werf F; Califf R; Pfeffer M
    J Am Coll Cardiol; 2006 Feb; 47(4):726-33. PubMed ID: 16487836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antihypertensive drug therapy--combination of AT1-receptor blocker and betablocker].
    Schindler C; Kosa M; Schröder J; Kirch W
    Dtsch Med Wochenschr; 2010 May; 135(3):98. PubMed ID: 20077385
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent changes in the landscape of combination RAS blockade.
    Epstein BJ; Smith SM; Choksi R
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CHARM].
    Momomura S
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():431-6. PubMed ID: 16981575
    [No Abstract]   [Full Text] [Related]  

  • 16. Angiotensin receptor blockers and myocardial infarction: the importance of dosage.
    Sarzani R; Dessì-Fulgheri P
    J Hypertens; 2006 Aug; 24(8):1679-81; author reply 1681-2. PubMed ID: 16877973
    [No Abstract]   [Full Text] [Related]  

  • 17. ARBs and mortality in myocardial infarction.
    Opie LH
    Cardiovasc J S Afr; 2005; 16(2):84. PubMed ID: 15915273
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with chronic kidney disease.
    Kolesnyk I; Struijk DG; Dekker FW; Krediet RT
    Neth J Med; 2010 Jan; 68(1):15-23. PubMed ID: 20103817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How should we play our hand when holding an ACE?
    Beattie WS
    Can J Anaesth; 2010 Aug; 57(8):720-4. PubMed ID: 20512539
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antihypertensive treatment for chronic kidney disease].
    Kumagai H; Hyodo T; Kushiyama T; Higashi K; Yamamoto K
    Nihon Rinsho; 2008 Aug; 66(8):1574-81. PubMed ID: 18700560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.